Source: Benzinga

Pyxis Oncology: Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a fireside chat on Monday, March 10, 2025 at 2:20 PM EST at the Leerink Partners Global Healthcare Conference in Miami, Florida.A live webcast and replay of the ...Full story available on Benzinga.com

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Lara S. Sullivan's photo - President & CEO of Pyxis Oncology

President & CEO

Lara S. Sullivan

CEO Approval Rating

90/100

Read more